Medifast (MED) Raw Materials (2011 - 2021)

Medifast (MED) has 9 years of Raw Materials data on file, last reported at $13.8 million in Q3 2021.

• For the quarter ending Q3 2021, Raw Materials rose 1.01% year-over-year to $13.8 million; the trailing twelve-month figure through Sep 2021 stood at $13.8 million (up 1.01% YoY), and the FY2020 full-year result was $13.4 million, up 23.42% from the prior year.
• Raw Materials for Q3 2021 stood at $13.8 million, up from $9.5 million in the prior quarter.
• Across five years, Raw Materials topped out at $13.8 million in Q3 2021 and bottomed at $4.3 million in Q3 2017.
• The 5-year median for Raw Materials is $10.5 million (2019), against an average of $9.6 million.
• The widest annual swing landed in 2017, when Raw Materials fell 27.71%; it then jumped 212.16% in 2018.
• A 5-year view of Raw Materials shows it stood at $4.3 million in 2017, then jumped by 156.58% to $11.2 million in 2018, then slipped by 2.47% to $10.9 million in 2019, then gained by 23.42% to $13.4 million in 2020, then increased by 3.07% to $13.8 million in 2021.
• The last three Raw Materials figures came in at $13.8 million (Q3 2021), $9.5 million (Q2 2021), and $11.2 million (Q1 2021), per Business Quant data.

Peer Comparison